FDA Grants Approval for Pimozide ANDA219897 by Novitium Pharma
The FDA has granted approval for ANDA219897, a generic formulation of Pimozide submitted by Novitium Pharma.
Company
Pharmaceutical intelligence for Novitium Pharma with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.